HNRC at CROI 2018

Several HNRC affiliated investigators contributed to the Conference on Retroviruses and Opportunistic Infections (CROI), March 4-7, 2018 in Boston, Massachusetts. Topics of presentations include evaluation of antiretroviral regimen effectiveness, methamphetamine use and aging, and biomarkers related to health and motor function.

Webcasts, abstracts, electronic posters, and other electronic resources from CROI 2018 will be available online after the conference.

Presentation titles are listed below.

De Almeida S, Ribeiro C, Rotta I, Piovesan M, Batistela Fernandes M, Tang B, Vaida F, Potter M, Letendre S, Ellis R. Cerebrospinal fluid and serum Neprilysin in patients infected eith HIV Clades C an B.

Ma Q, Ocque A, Morse G, Sanders C, Burgi A, Little S, Letendre S. Switching to TAF in EVG-based regimens: CSF pharmacokinetics and antiviral activity.

Mehta S, Iudicello J, Ellis R, Lin J, Morgan E, Cookson D, Heaton R, Grant I, Letendre S. Methamphetamine use independently predicts premature aging in HIV+ individuals.

Montoya J, Letendre S, Ellis R, Jeste D, Moore D. Plasma d-dimer relates to physical health and motor skills across the age span in HIV.

Mukerji S, Misra I, Lorenz D, Uno H, Morgello S, Franklin D, Ellis R, Letendre S, Gabuzda D. Impact of ART regimens on CSF viral escape in HIV-1 infected adults.

Copyright ©2009 HIV Neurobehavioral Research Center | University of California, San Diego
HNRP | For questions regarding this site, please contact the webmaster